What is Icatibant?

The short answer

Icatibant is a peptide, a short chain of amino acids. In the US, you need a prescription to get Icatibant.

Get updates on Icatibant

What it is

Type
Bradykinin B2 receptor antagonist (peptide)
Also known as
firazyr

Regulatory status

FDA-approved (Rx) How we label status

As of October 4, 2026, Icatibant is an FDA-approved prescription drug for acute attacks of hereditary angioedema.

See Icatibant in the Index →

Federal (FDA)
Approved Rx (Firazyr NDA022150, 2011; generics)
503A compounding
Approved-drug component (not in any 503A category) (as of May 14, 2026)

References

Sources as of October 4, 2026

  1. DailyMed: dailymed.nlm.nih.gov/dailymed/drugInfo.cfm